Exane BNP Paribas Upgrades Corteva to Neutral, Announces $53 Price Target
Portfolio Pulse from Benzinga Newsdesk
Exane BNP Paribas analyst Laurent Favre upgrades Corteva (NYSE:CTVA) from Underperform to Neutral and sets a $53 price target.
February 02, 2024 | 11:18 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Corteva upgraded to Neutral from Underperform by Exane BNP Paribas with a new price target of $53.
The upgrade from Underperform to Neutral by a notable analyst, along with a set price target of $53, indicates a positive shift in sentiment towards Corteva. This could lead to increased investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100